DOTA-NHS Hexafluorophosphate Trifluoroacetate>95.0%(T)100mg

(6-Cyclobutoxypyridin-3-yl)methanamine, 95.0%, 250mg

4-amino-1-(3,4-dihydroxy-5-(hydroxymethyl)-3-methyltetrahydrofuran-2-yl)pyrimidin-2(1H)-one, 95.0%, 250mg

5-Benzyloxy-indoline hydrochloride, 97.0%, 1g

2,7-DIAZASPIRO[4.5]DECANE-7-CARBOXYLIC ACID, 1,1-DIMETHYLETHYL ESTER, HCL, 95.0%, 250mg

(1R,4S)-Dimethyl 1-((R)-1-(phenylamino)-2-(p-tolyl)ethyl)-7-oxabicyclo[2.2.1]hepta-2,5-diene-2,3-dicarboxylate, 98.00%, 25mg

5-BROMO-3-IODOPYRAZOLO[1,5-A]PYRIDINE, 95.0%, 250mg

Coperchio a flangia piatta DURAN® 4 colli con collo centrale NS, 3 colli laterali inclinati, DN 100, 138 mm, Altezza, 105 mm, 1 Pezzo

(6-Chloro-2-fluoropyridin-3-yl)boronic acid, 95.0%, 5g

5-Amino-1-ethyl-1H-1,2,3-triazole-4-carboxamide, 95.0%, 250mg

Tris(trimethylsiloxy)silylethyltriethoxy-silane, 10g

4-(3-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)pyridin-2-yl)morpholine, 95.0%, 5g

(3-Bromothiophen-2-yl)methanamine hydrochloride, 95+%, 50mg